The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Well done to those invested here. The tip hit my inbox this morning, I did not invest no funds. :(
I am not in, it is just someone asked if it had been tipped due to the large volume. Oxa will be huge if they get it right.
If oxa get it right this is a life changer
They never do. The company is more hands on than alot of others.
No. I got in big trouble last time under the Ts and Cs
Tipped it this morning
Cupid are not portrayed in a very good light, talk about stitching people up.
The link worked on my iphone.
Saturday 13 July 2013 American companies are sitting on a serious amount of cash. It is reckoned that collectively they are hoarding as much as $1.4 trillion, which translates to almost £1 trillion, about the worth of the British economy. More than half the money is held overseas because of the prohibitive taxes that have to be paid when US companies repatriate the cash. Consequently, the overseas cash pile could continue to swell unless the US government relaxes the rules regarding the remittance of money back to America by US companies. Most of us are already aware of Apple’s cash hoard – it is estimated to be worth about $140bn. But Apple isn’t the only company that is drowning in cash – a host of other hi-tech businesses are in similar positions. These include Microsoft, Google and Cisco Systems that together hold $162bn in readies. Elsewhere, pharmaceutical giant Pfizer is estimated to have a cash pile of $46bn – enough to buy somewhere like Macao. Interestingly for investors and also for global economies, US corporations could more than take up the slack should the US Treasury decide to scale back its money-printing programme. The quantity of cash held by US businesses is more than 16 times the amount of money that Ben Bernanke has been pumping into the US economy every month. The question is, though, what could these cash-rich US companies do with their war chest? We know some of the cash has been used for capital expenditure. Some has been used to buy back shares and some to boost dividends. In fact, several companies have also made strategic acquisitions, which could turn out to be a recurring theme in coming years. In the hi-tech sector, which is where most of the cash is, Google has already made a $1.3bn swoop for traffic-mapping and navigation outfit Waze. The deal, which is subject to regulatory approval, effectively cements Google’s position as the main player in mapping and navigation, particularly for motorists. But with $48bn in its coffers, it barely makes a dent in its cash mountain. Pharmaceutical giants Pfizer and Amgen are together holding as much as $70bn. Last year Pfizer, which has a cash pile of $46bn, ruled out any mega-acquisitions. That said, it indicated that it remained on the lookout for small bolt-on purchases. Oncology, which is an area that Pfizer might be interested in, could bring Oxford BioMedica into play. The company, which already counts Pfizer as one of its partners, develops gene-based therapies. The two companies currently have a partnership for the development of an antibody for the treatment of cancer. Scancell, which is developing a vaccine for melanoma, is another interesting company that could whet the appetite of cash-rich Pfizer. When cash is burning a hole in your pocket there can be a temptation to spend the money quickly. So, American corporations that are sitting on a mountain of cash could find the lure of cheap assets abroad too muc
You sound like a sheep follow the heard lol
I think you are inanaco stalker watching his every move. It is like Millymog saying where he is going for dinner who really cares. Inanaco likes to help people but millymog gives the impression he has to feel important when in actual fact he is not someone I just laugh at.
Your posts crack me up. Lol
Faraday sold this with a 5% loss. They had a licensing deal June last year I think for 9 months but no news. If you can lock your money up you should be okay. Disclaimer. I don't hold a position here.
You will be reincarnated before you make any money here.
I hope it is not financial advice. Lol
Not board. Anyway must dash need to eat. See you at 3p lol
How is that not profitable. Dear xxxx Its true that until recently we had anticipated a trade sale at the conclusion of our SCIB1 ImmunoBody study. That remains the earliest point at which a trade sale could realistically be contemplated. Our decision to raise additonal capital to kick start the development of Moditope has complicated the picture somewhat. However the Board remains firmly committed to a trade sale when signicant shareholder value has been created on both the ImmunoBody® and Moditope™ platforms. Its very hard to say at present precisely when such a position will have been reached. Kind regards Richard Goodfellow
That is one of many you have alot to learn. Lol
There are more profitable companies. So no thanks.
I am doing all right on the investment front at the mo. there are other companies that I get a good feeling for and this is not one. Looks a lot of tosh. Dyor lol